Morgan Stanley Black Diamond Therapeutics, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 125,004 shares of BDTX stock, worth $273,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,004

Previous 216,328 42.22%

Holding current value

$273,758

Previous $1.01 Million 46.13%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.2 - $6.58 $383,560 - $600,911	-91,324 Reduced 42.22%	125,004 $543,000
Q2 2024 Oct 17, 2024	BUY	$4.65 - $7.39 $732,049 - $1.16 Million	157,430 Added 267.29%	216,328 $1.01 Million
Q2 2024 Aug 14, 2024	BUY	$4.65 - $7.39 $732,049 - $1.16 Million	157,430 Added 267.29%	216,328 $1.01 Million
Q1 2024 Oct 17, 2024	SELL	$2.67 - $5.74 $420,338 - $903,648	-157,430 Reduced 72.77%	58,898 $298,000
Q1 2024 Aug 16, 2024	BUY	$2.67 - $5.74 $125,668 - $270,164	47,067 Added 397.83%	58,898 $298,000
Q1 2024 May 15, 2024	BUY	$2.67 - $5.74 $125,668 - $270,164	47,067 Added 397.83%	58,898 $298,000
Q4 2023 Aug 16, 2024	SELL	$1.77 - $3.03 $361,959 - $619,625	-204,497 Reduced 94.53%	11,831 $33,000
Q4 2023 Feb 13, 2024	SELL	$1.77 - $3.03 $18,089 - $30,966	-10,220 Reduced 46.35%	11,831 $33,000
Q3 2023 Nov 15, 2023	BUY	$2.87 - $4.99 $16,594 - $28,852	5,782 Added 35.54%	22,051 $63,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $16,738 - $72,336	-11,705 Reduced 41.84%	16,269 $82,000
Q1 2023 May 15, 2023	SELL	$1.35 - $3.14 $4,357 - $10,135	-3,228 Reduced 10.35%	27,974 $52,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.51 $251,443 - $496,947	-197,987 Reduced 86.39%	31,202 $56,000
Q3 2022 Nov 14, 2022	SELL	$1.68 - $4.01 $515,812 - $1.23 Million	-307,031 Reduced 57.26%	229,189 $387,000
Q2 2022 Oct 27, 2022	BUY	$1.5 - $3.63 $64,287 - $155,574	42,858 Added 8.69%	536,220 $1.32 Million
Q2 2022 Aug 15, 2022	BUY	$1.5 - $3.63 $64,287 - $155,574	42,858 Added 8.69%	536,220 $1.32 Million
Q1 2022 Oct 27, 2022	SELL	$2.66 - $5.61 $114,002 - $240,433	-42,858 Reduced 7.99%	493,362 $1.37 Million
Q1 2022 May 13, 2022	SELL	$2.66 - $5.61 $746,326 - $1.57 Million	-280,574 Reduced 36.25%	493,362 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $66,537 - $108,925	12,845 Added 1.69%	773,936 $4.13 Million
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $6.44 Million - $9.45 Million	761,091 New	761,091 $6.44 Million

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.6M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account